Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;2(9):1844-1866.
doi: 10.3390/v2091844. Epub 2010 Aug 27.

Increasing the efficacy of oncolytic adenovirus vectors

Karoly Toth  1 , William S M Wold  1
Affiliations

Increasing the efficacy of oncolytic adenovirus vectors

Karoly Toth et al. Viruses. 2010 Sep.

Abstract

Oncolytic adenovirus (Ad) vectors present a new modality to treat cancer. These vectors attack tumors via replicating in and killing cancer cells. Upon completion of the vector replication cycle, the infected tumor cell lyses and releases progeny virions that are capable of infecting neighboring tumor cells. Repeated cycles of vector replication and cell lysis can destroy the tumor. Numerous Ad vectors have been generated and tested, some of them reaching human clinical trials. In 2005, the first oncolytic Ad was approved for the treatment of head-and-neck cancer by the Chinese FDA. Oncolytic Ads have been proven to be safe, with no serious adverse effects reported even when high doses of the vector were injected intravenously. The vectors demonstrated modest anti-tumor effect when applied as a single agent; their efficacy improved when they were combined with another modality. The efficacy of oncolytic Ads can be improved using various approaches, including vector design, delivery techniques, and ancillary treatment, which will be discussed in this review.

Keywords: adenovirus; replication competent; tumor; virotherapy.

PubMed Disclaimer

References

    1. Toth K, Dhar D, Wold WS. Oncolytic (replication-competent) adenoviruses as anticancer agents. Exp Opin Biol Ther. 2010;10:353–368. - PubMed
    1. Wold WSM, Horwitz MS. Adenoviruses. In: Knipe DM, Howley PM, editors. Field’s Virology. 5th Edition. Lippincott, Williams, & Wilkins; Philadelphia, PA, USA: 2007. pp. 2395–2436.
    1. Lichtenstein DL, Wold WSM. Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission. Cancer Gene Ther. 2004;11:819–829. - PubMed
    1. Berk AJ. Adenoviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM, editors. Field’s Virology. 5th Edition. Lippincott, Williams, & Wilkins; Philadelphia, PA, USA: 2007. pp. 2355–2394.
    1. Russell WC. Adenoviruses: update on structure and function. J Gen Virol. 2009;90:1–20. - PubMed

LinkOut - more resources